Healthcare provider profile · identity verified

Joaquin Rodriguez, M.D.

Internal Medicine · MIAMI, FL · NPI 1740221399

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	449	151
Rosuvastatin Calcium	Rosuvastatin Calcium	296	92
Omeprazole	Omeprazole	255	56
Losartan Potassium	Losartan Potassium	248	84
Gabapentin	Gabapentin	229	68
Vitamin D2	Ergocalciferol (Vitamin D2)	228	68
Metformin Hcl	Metformin Hcl	226	69
Amlodipine Besylate	Amlodipine Besylate	195	48
Metoprolol Succinate	Metoprolol Succinate	194	55
Pantoprazole Sodium	Pantoprazole Sodium	184	47
Eliquis	Apixaban	161	27
Lisinopril	Lisinopril	151	51
Famotidine	Famotidine	150	38
Montelukast Sodium	Montelukast Sodium	137	31
Levothyroxine Sodium	Levothyroxine Sodium	129	38
Ezetimibe	Ezetimibe	126	29
Hydrochlorothiazide	Hydrochlorothiazide	124	39
Albuterol Sulfate Hfa	Albuterol Sulfate	115	24
Nifedipine Er	Nifedipine	112	19
Ozempic	Semaglutide	107	13
Diclofenac Sodium	Diclofenac Sodium	104	57
Clopidogrel	Clopidogrel Bisulfate	92	29
Carvedilol	Carvedilol	87	19
Olmesartan Medoxomil	Olmesartan Medoxomil	82	25
Tamsulosin Hcl	Tamsulosin Hcl	82	29
Atenolol	Atenolol	78	18
Fluticasone Propionate	Fluticasone Propionate	77	19
Furosemide	Furosemide	77	20
Meloxicam	Meloxicam	75	20
Metoprolol Tartrate	Metoprolol Tartrate	71	21
Allopurinol	Allopurinol	70	17
Enalapril Maleate	Enalapril Maleate	69	17
Hydralazine Hcl	Hydralazine Hcl	68	16
Memantine Hcl	Memantine Hcl	68	17
Januvia	Sitagliptin Phosphate	67	suppressed
Sildenafil Citrate	Sildenafil Citrate	67	14
Trazodone Hcl	Trazodone Hcl	67	20
Alendronate Sodium	Alendronate Sodium	60	14
Glimepiride	Glimepiride	60	17
Farxiga	Dapagliflozin Propanediol	58	12
Temazepam	Temazepam	58	11
Bumetanide	Bumetanide	57	12
Glipizide	Glipizide	56	16
Clonazepam	Clonazepam	55	11
Azithromycin	Azithromycin	54	49
Prednisone	Prednisone	54	31
Oxybutynin Chloride Er	Oxybutynin Chloride	53	13
Clonidine Hcl	Clonidine Hcl	48	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	43	22
Dicyclomine Hcl	Dicyclomine Hcl	43	15
Pentoxifylline	Pentoxifylline	42	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	41	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	38	suppressed
Chlorthalidone	Chlorthalidone	37	suppressed
Hydrocortisone	Hydrocortisone	37	suppressed
Simvastatin	Simvastatin	37	11
Alcohol Prep Pads	Alcohol Antiseptic Pads	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	35	suppressed
Cholestyramine	Cholestyramine (With Sugar)	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Xarelto	Rivaroxaban	32	suppressed
Ibuprofen	Ibuprofen	31	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Valsartan	Valsartan	29	suppressed
Levofloxacin	Levofloxacin	28	26
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Ketoconazole	Ketoconazole	26	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	20
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	12
Tramadol Hcl	Tramadol Hcl	25	suppressed
Glipizide Er	Glipizide	24	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	22	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	22	suppressed
Pregabalin	Pregabalin	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Finasteride	Finasteride	20	suppressed
Folic Acid	Folic Acid	20	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Methocarbamol	Methocarbamol	20	12
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Linzess	Linaclotide	19	suppressed
Benzonatate	Benzonatate	18	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Mupirocin	Mupirocin	15	suppressed
Cilostazol	Cilostazol	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	14
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Cephalexin	Cephalexin	13	13
Propranolol Hcl	Propranolol Hcl	13	suppressed
Jentadueto	Linagliptin/Metformin Hcl	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Trueplus Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	11	suppressed
Ciclopirox	Ciclopirox Olamine	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Prolia	Denosumab	11	suppressed
Risedronate Sodium	Risedronate Sodium	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error